MR

Muralidhara Ramachandra

Active Director Ceo DIN 10561973
DIN 10561973 First appointment Jul 2019 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Jul 2019
Shareholding value •••• Premium profile

About Muralidhara Ramachandra

Data last updated:

Muralidhara Ramachandra is a Ceo at Aurigene Oncology Limited (since 2019) and Director at Dr.Reddy's Institute Of Life Sciences (since 2024). The companies operate in Life Sciences, Pharma and Tourism And Accommodation. The 2 current companies with reported revenue have a combined latest revenue of ₹194 Cr; the largest is Aurigene Oncology Limited at ₹172 Cr (FY 2025). Earlier, Muralidhara Ramachandra was an Additional Director at Adhyaya Resorts And Spa Private Limited (2024–2025).

DIN 10561973
Primary Designation Ceo
Industry Life Sciences
First Appointment 01 Jul 2019
Oldest Company Age 25 yrs
Largest company Aurigene Oncology Limited · ₹172 Cr (FY 2025)
Combined revenue ₹194 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aurigene Oncology Limited U24239KA2001PLC029391
Ceo01 Jul 20192001₹172 Cr (FY 2025)Active
Director23 Apr 20242003₹22.14 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director28 Aug 20242024Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aurigene Oncology Limited
Dr.Reddy's Institute Of Life Sciences
Adhyaya Resorts And Spa Private Limited
Premium access

Shareholding and investment profile for Muralidhara Ramachandra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muralidhara Ramachandra

Muralidhara Ramachandra currently holds 2 directorships: Aurigene Oncology Limited (Ceo, since 01 Jul 2019, revenue ₹172 Cr (FY 2025)); Dr.Reddy's Institute Of Life Sciences (Director, since 23 Apr 2024, revenue ₹22.14 Cr (FY 2025)).

Muralidhara Ramachandra was first appointed on 01 Jul 2019 as Ceo at Aurigene Oncology Limited. The most recent appointment on record is 28 Aug 2024 at Adhyaya Resorts And Spa Private Limited.

The 2 current companies of Muralidhara Ramachandra that report revenue have a combined latest revenue of ₹194 Cr: Aurigene Oncology Limited ₹172 Cr (FY 2025); Dr.Reddy's Institute Of Life Sciences ₹22.14 Cr (FY 2025).

Muralidhara Ramachandra held 1 earlier board appointment: Adhyaya Resorts And Spa Private Limited (Additional Director, 28 Aug 2024 to 03 Nov 2025).

The current boards of Muralidhara Ramachandra's companies include Brijesh Kumar Karnani (Aurigene Oncology Limited), Bruce Leonard Andrews Carter (Aurigene Oncology Limited), Buggana Hariharnath (Aurigene Oncology Limited), Kumar Srinivasan (Aurigene Oncology Limited), Satish Reddy Kallam (Aurigene Oncology Limited), Shubhada Vivek Chiplunkar (Aurigene Oncology Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available